Expressed and secreted from melanoma cells but not from immune cells [37], sCEACAM1 might act in a similar manner as a soluble agonistic ligand, which activates membrane-bound CEACAM1 receptors on NK and T cells thereby inhibiting their effector functions. The gene discussed is CEACAM1; the disease is melanoma.